The population based socioeconomic burden of pediatric influenza-associated hospitalization in Hong Kong

Vaccine

Volumn 30, Issue 10, 2012, Pages 1895-1900

  Chiu, Susan S ^a   Chan, Kwok Hung ^a   So, Lok Yee ^b   Chen, Robin ^b   Chan, Eunice L Y ^a   Peiris, J S M ^a,c  

^a UNIVERSITY OF HONG KONG   (Hong Kong)

^b PAMELA YOUDE NETHERSOLE EASTERN HOSPITAL   (Hong Kong)

^c HKU PASTEUR RESEARCH CENTRE   (Hong Kong)

Author keywords

Influenza; Pediatric; Socioeconomic burden

Indexed keywords

ABSENTEEISM; ADOLESCENT; ARTICLE; CHILD; CHILD HOSPITALIZATION; CHILDHOOD DISEASE; COST CONTROL; FEMALE; HEALTH CARE COST; HONG KONG; HUMAN; INFANT; INFLUENZA A; INFLUENZA B; INFLUENZA VACCINATION; MAJOR CLINICAL STUDY; MALE; MEDICAL LEAVE; NEWBORN; PARENT; POPULATION RESEARCH; PRESCHOOL CHILD; PRIORITY JOURNAL; PRODUCTIVITY; PROSPECTIVE STUDY; SCHOOL CHILD; SOCIOECONOMICS; VIRUS INFECTION;

ADOLESCENT; CHILD; CHILD, PRESCHOOL; COST OF ILLNESS; FEMALE; HONG KONG; HOSPITALIZATION; HUMANS; INFANT; INFLUENZA VACCINES; INFLUENZA, HUMAN; MALE; PROSPECTIVE STUDIES; SICK LEAVE;

EID: 84857459188     PISSN: 0264410X     EISSN: 18732518     Source Type: Journal    
DOI: 10.1016/j.vaccine.2011.12.027     Document Type: Article

References (45)

1. Neuzil K.M., Hohlbein C., Zhu Y. Illness among schoolchildren during influenza season. Arch Pediatr Adolesc Med 2002, 156:986-991.
2. Hall J., Latz B.Z. Cost of influenza hospitalization at a tertiary care children's hospital and its impact on the cost-benefit analysis of the recommendation for universal influenza immunization in children age 6 to 23 months. J Pediatr 2005, 147:807-811.
3. Ampofo K., Gesterland P.H., eta al. Bender J. Epidemiology, complications, and cost of hospitalization in children with laboratory-confirmed influenza infection. Pediatrics 2006, 118:2409-2417.
4. Li S., Leader S. Economic burden and absenteeism from influenza-like illness in healthy households with children (5-17 years) in the US. Respir Med 2006, 101:1244-1250.
5. Keren R., Zoutis T.E., Saddlemire S., Luan X.Q., Coffin S.E. Direct medical cost of influenza-related hospitalizations in children. Pediatrics 2006, 118:e1321-e1327.
6. Molinari N-A., Ortega-Sanchez I.R., Messonnier M.L., Thompson W.W., Wortley P.M., Weintraub E., et al. The annual impact of seasonal influenza in the US: measuring disease burden and costs. Vaccine 2007, 25:5086-5096.
7. Fairbrother G., Cassedy A., Ortega-Sanchez I.R., Szilagyi P.G., Edwards K.M., Molinari N.-A., et al. High costs of influenza: direct medical costs of influenza disease in young children. Vaccine 2010, 28:4913-4919.
8. Esposito S., Cantarutti L., Molteni C.G., Daleno C., Scala A., Tagliabue C., et al. Clinical manifestations and socio-economic impact of influenza among healthy children in the community. J Infect 2011, 62:379-387.
9. White T., Lavoie S., Nettleman M.D. Potential cost savings attributable to influenza vaccination of school-aged children. Pediatrics 1999, 103:e73.
10. Cohen G.M., Nettleman M.D. Economic impact of influenza vaccination in preschool children. Pediatrics 2000, 106:973-976.
11. Fitzner K.A., Shortridge K.F., McGhee S.M., Hedley A.J. Cost-effectiveness study on influenza prevention in Hong Kong. Health Policy 2001, 56:215-234.
12. Dayan G.H., Nguyen V.H., Debbag R., Gomez R., Wood S.C. Cost-effectiveness of influenza vaccination in high-risk children in Argentina. Vaccine 2001, 19:4204-4213.
13. Luce B.R., Zangwill K.M., Palmer C.S., Mendelman P.M., Yan L., Wolff M.C., et al. Cost-effectiveness analysis of an intranasal influenza vaccine for the prevention of influenza in healthy children. Pediatr 2001, 108:e24.
14. Turner D., Wailoo A., Nicholson K., Cooper N., Sutton A., Abrams K. Systematic review and economic decision modeling for the prevention and treatment of influenza A and B. Health Technol Assess 2003, 7:3-13. 1.
15. Ipp M., Young N.L., To T., Cheng A., Lan F., Wang E.E.L. Influenza vaccination options to prevent hospitalization. Paediatr Child Health 2003, 8:6203.
16. Nichol K.L. The efficacy, effectiveness and cost-effectiveness of inactivated influenza virus vaccines. Vaccine 2003, 21:1769-1775.
17. Principi N., Esposito S., Marchisio P., Gasparini R., Crovari P. Socioeconomic impact of influenza on healthy children and their families. Pediatr Infect Dis J 2003, 22:S207-S210.
18. Meltzer M.I., Neuzil K.M., Griffin mR.Fukuda K. An economic analysis of annual influenza vaccination of children. Vaccine 2005, 23:1004-1014.
19. Weycker D., Edelsberg J., Halloran M.E., Longini I.M., Nizam A., Ciuryla V., et al. Population-wide benefits of routine vaccination of children against influenza. Vaccine 2005, 23:1284-1293.
20. Skowronski D.M., Woolcott J.C., Tweed S.A., Brunham R.C., Marra F. Potential cost-effectiveness of annual influenza vaccination for infants and toddlers: experience from Canada. Vaccine 2006, 24:422-4234.
21. Salo H., Sintonen H., Linna M., Peltola V.M., Heikkinen T. Cost-effectiveness of influenza vaccination of healthy children. Vaccine 2006, 24:4934-4991.
22. Marchetti M., Kuhnel U.M., Esposito S., Principi N. Cost-effectiveness of adjuvanted influenza vaccination of healthy children 6 to 60 months of age. Human Vaccin 2007, 3:14-22.
23. Luce B.R., Nichol K.L., Belshe R.B., Frick K.D., Li S.X., Boscoe A., et al. Cost-effectiveness of live attenuated influenza vaccine versus inactivated influenza vaccine among children aged 24-59 months. Vaccine 2008, 26:2841-2848.
24. Chiu S.S., Chan K.-H., Chen H., Young B.W., Lim W., Wong W.H.S., et al. Virologically confirmed population-based burden of hospitalization caused by Influenza A and B in Children in Hong Kong. Clin Infect Dis 2009, 49:1016-1021.
25. http://www.statistics.gov.hk/publication/stat_report/social_data/B11302302007XXXXB0100.pdf.
26. The Bauhinia Foundation Research Centre website: Development and Financing of Hong Kong's Future Health Care. Available from: [accessed 20.07.11]. http://www.bauhinia.org/publications/BFRC-HC-FR-EN.pdf.
27. The Government of the Hong Kong Special Administrative Region. Centre for Health Protection website: Influenza Vaccination Subsidy Scheme. Available from: [accessed 20.07.11]. http://www.dh.gov.hk/english/press/2008/081030-2.html.
28. Neuzil K.M., Dupont W.D., Wright P., Edwards K.M. Efficacy of inactivated and cold-adapted vaccines against influenza A infection, 1985 to 1990: the pediatric experience. Pediatr Infect Dis J 2001, 20:733-740.
29. Eisenberg K.W., Szilagyi P.G., Fairbrother G., Griffin M.R., Staat M., Shone L.P., et al. Vaccine effectiveness against laboratory confirmed influenza in children 6 to 59 months of age during the 2003-2004 and 2004-2005 influenza seasons. Pediatrics 2008, 122:911-919.
30. Clover R.D., Crawford S., Glezen W.P., Taber L.H., Matson C.C., Couch R.B., et al. Comparison of heterotypic protection against influenza A/Taiwan/86 (H1N1) by attenuated and inactivated vaccines to A/Chile/83-like viruses. J Infect Dis 1991, 163:300-304.
31. Chan K.H., Maldeis N., Pope W., Yup A., Ozinskas A., Gill J., et al. Evaluation of the Directigen FluA+B test for rapid diagnosis of influenza virus type A and B infections. J Clin Microbiol 2002, 40:1675-1680.
32. Stephen A.Y., McLaren L.C. Hemadsorption and hemagglutination inhibition. Clinical virology manual 2000, 135-139. 3rd ed. S. Specter, R.L. Hodinka, S.A. Young (Eds.).
33. Simmerman J.M., Lertiendumrong J., Dowell S.F., Uyeki T., Olsen S.J., Chittaganpitch M., et al. The cost of influenza in Thailand. Vaccine 2006, 4417-4426.
34. Palmer L.A., Rousculp M.D., Johnston S.S., Mahadevia P.J., Nichol K.L. Effect of influenza-like illness and other wintertime respiratory illnesses on worker productivity: the child and household influenza-illness and employee function (CHIEF) study. Vaccine 2010, 28:5049-5056.
35. Foy H.M., Cooney M.K., Allan I. Longitudinal studies of type A and B influenza among Seattle schoolchildren and families, 1968-1974. J Infect Dis 1976, 13:362-369.
36. Glezen W.P., Couch R.B. Interpandemic influenza in the Houston area, 1974-76. N Engl J Med 1978, 298:587-592.
37. Fox J.P., Hall C.E., Cooney M.K., Foy H.M. Influenza virus infections in Seattle families, 1975-1979: study design, methods, and the occurrence of infections by time and age. Am J Epidemiol 1982, 116:212-227.
38. Longini I.M., Koopman J.S., Monto A.S., Fox J.P. Estimating household and community transmission parameters for influenza. Am J Epidemiol 1982, 115:736-751.
39. Iskander M., Kesson A., Dwyer D., et al. The burden of influenza in children under 5 years admitted to the children's hospital at Westmead in the winter of 2006. J Paediatr Child Health 2009, 45:698-703.
40. Simmerman J.M., Suntarattiwong P., Levy J., Jarman R.G., Kaewchana S., Gibbons R.V., et al. Findings from a household randomized controlled trial of hand washing and face masks to reduce influenza transmission in Bangkok, Thailand. Influenza Other Respir Viruses 2011, 5:256-267.
41. Allison M.A., Daley M.F., Crane L.A., Barrow J., Beaty B.L., Alfred N., et al. Influenza vaccine effectiveness in healthy 6- to 21-month-old children during the 2003-2004 season. J Pediatr 2006, 149:755-762.
42. Belshe R.B., Coelingh K., Ambrose C.S., Woo J.C., Wu X. Efficacy of live attenuated influenza vaccine in children against influenza B viruses by lineage and antigenic similarity. Vaccine 2010, 28:2149-2156.
43. Belshe R.B. The need for quadrivalent vaccine against seasonal influenza. Vaccine 2010, 28S:D45-D53.
44. Monto A.S., Davenport Fm Modification of an outbreak of influenza in Tecumseh, Michigan, by vaccination of school children. J Infect Dis 1970, 122:16-25.
45. Reichert T.A., Sugaya N., Fedson D.S., Glezen W.P., Simonsen L., Tashiro M. The Japanese experience with vaccinating school children against influenza. N Engl J Med 2001, 344:889-896.